---

Aim and Background: The present study aimed to investigate the role of meta-cognitive beliefs, personality type D, and psychological well-being in the prediction of symptoms severity in psoriasis. Methods and Materials : This was a descriptive correlational study. The research population consisted of all individuals who referred to skin clinics in Kermanshah, Iran, for the treatment of psoriasis in 3014. The participants consisted of 115 individuals who were selected through convenience sampling. Among the participants, 51 were men. After the completion of the Psoriasis Area and Severity Index (PASI) by a physician, the Type D personality scale, Ryff’s Psychological Well-Being Questionnaire, the Meta-Cognition Questionnaire (Cartwright Hutton and Wales) were completed by the subjects. Findings: Meta-cognitive beliefs and type D personality had a significant negative relationship with psychological well-being. Moreover, meta-cognitive beliefs and personality type D predict the severity of psoriasis symptoms through the reduction of psychological well-being. Conclusions: The enhancement of individual well-being in all its components through appropriate psychological training interventions can help to speed up the treatment of patients with this disease.

---

Aim and Background: Reducing sex hormones in men with various physical and psychological problems, including depression, decreased physical activity, impairment in memory, and executive functions.The purpose of this study was to compare mental health between andropause and normal men in order to identify the psychological aspects of andropause . Methods and Materials: The present study was a causal-comparative study and 150 men were selected as the research sample from the male employees of Tehran Medical University who aged 45-65 years. After filling Androgen Deficiency of Aging Men (ADAM) questionnaire and General Health Questionnaire (GHQ), participants divided into two groups; normal and andropause clinical diagnosis. Who received androgen-deficiency syndrome by the questionnaire referred to the lab in order to biochemical diagnosis of andropause. Findings: There were significant differences between this three groups in terms of physical symptoms, social function, anxiety and depression, and those who received a laboratory diagnosis of andropause reported more depression and anxiety . Conclusions: According to the result, who received andropause laboratory diagnosis had severe depression and anxiety that indicates the necessity of using psychotherapy along with hormonal and other therapies for andropause .

---

Aim and Background: Anxiety can lead to heart disease in a 10-year interval, and heart disease, in turn, leads to anxiety; death anxiety. The purpose of this study was to determine the effectiveness of group schema therapy on reducing the death anxiety in cardiovascular patients. Methods and Materials: The statistical population included all patients with cardiovascular disease referred to Tehran heart center. The sampling method was of convenience and the research design was semi-experimental with the experimental and control groups including pre-test and post-test. Initially, the data from the Templer death anxiety scale were collected from 113 individuals and after a primary evaluation 30 individuals (18 women and 12 men) from the participants who had the highest marks in the test were involved in the research and assigned randomly to two experimental and control groups. It was previously considered that the participants did not suffer from a nervous condition disturbing consciousness, such as head injury and dementia. Then, the members of the experimental group were intervened for 12 sessions of 90 minutes by group schema therapy and after that, they were evaluated again in terms of the degree of death anxiety. Data were analyzed by SPSS version 23. Findings: The results showed that after the implementation of the schema therapy, the death anxiety level of the experimental group significantly decreased (p< 0.05, F= 147.4). Therefore, the hypothesis of the research on the effectiveness of group schema therapy on reducing death anxiety is confirmed. Conclusions: This finding may contribute to the current research vacuum regarding death anxiety in cardiovascular patients as well as to clinical applications in the face of this phenomenon.